| Active Not Recruiting | Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities Actinic Keratosis | Phase 3 | 2025-11-29 |
| Active Not Recruiting | Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp Actinic Keratosis | Phase 3 | 2025-11-19 |
| Recruiting | Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata Alopecia Areata | Phase 3 | 2025-08-05 |
| Completed | A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment Acne Vulgaris | Phase 1 | 2025-08-04 |
| Completed | A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIA Acne Vulgaris | Phase 1 | 2024-06-20 |
| Completed | A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pha Acne Vulgaris | Phase 1 | 2024-05-13 |
| Completed | A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicol Tinea Versicolor | Phase 1 | 2023-12-04 |
| Completed | A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Atopic Dermatitis | Phase 1 | 2023-08-11 |
| Completed | A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 1 | 2023-02-22 |
| Completed | European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata Alopecia Areata | Phase 3 | 2021-10-19 |
| Completed | A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobe Plaque Psoriasis | EARLY_Phase 1 | 2021-04-16 |
| Completed | A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis. Tinea Pedis | EARLY_Phase 1 | 2020-09-03 |
| Completed | A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment o Acne Vulgaris | EARLY_Phase 1 | 2020-08-31 |
| Completed | A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris Acne Vulgaris | EARLY_Phase 1 | 2020-05-18 |
| Completed | A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris Acne Vulgaris | EARLY_Phase 1 | 2019-12-10 |
| Completed | Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 1 | 2019-09-09 |
| Active Not Recruiting | Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata Alopecia Areata | Phase 2 / Phase 3 | 2019-04-04 |
| Completed | Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 1 | 2019-03-20 |
| Completed | To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis Scalp Psoriasis | Phase 1 | 2018-10-22 |
| Completed | An Open-Label Study to Assess Safety Plaque Psoriasis | Phase 1 | 2018-04-04 |
| Completed | Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream Bioequivalence Study | Phase 1 | 2018-03-02 |
| Completed | A Study Comparing Oxymetazoline 1% Cream to RHOFADE Bioequivalence | Phase 1 | 2018-02-23 |
| Completed | To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea Rosacea | Phase 1 | 2017-12-12 |
| Completed | To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne V Acne Vulgaris | EARLY_Phase 1 | 2017-08-21 |
| Completed | To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Acne Vulgaris | EARLY_Phase 1 | 2017-08-04 |
| Completed | A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5% Lice; Head Lice | Phase 1 | 2017-03-20 |
| Completed | Efficacy Study in Patients With Acne Vulgaris. Acne Vulgaris | Phase 2 | 2016-10-03 |
| Completed | An Open Label, Safety Study to Assess the Potential for Adrenal Suppression Plaque Psoriasis | Phase 2 | 2016-09-02 |
| Completed | Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 1 | 2016-08-08 |
| Completed | An Open Label, Safety Study to Assess the Potential for Adrenal Suppression. Atopic Dermatitis | Phase 2 | 2016-08-01 |
| Completed | Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS Psoriasis | Phase 2 | 2016-07-11 |
| Completed | Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product Scalp Psoriasis | Phase 2 | 2016-07-11 |
| Completed | To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel Rosacea | Phase 1 | 2016-07-01 |
| Completed | Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study Onychomycosis | Phase 2 | 2016-03-21 |
| Completed | Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis Scalp Psoriasis | Phase 3 | 2016-03-11 |
| Completed | Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis Scalp Psoriasis | Phase 3 | 2016-03-01 |
| Completed | Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2015-09-04 |
| Completed | Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Ps Plaque Psoriasis | Phase 2 | 2015-09-04 |
| Completed | Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris Acne Vulgaris | Phase 1 | 2015-09-01 |
| Completed | Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2015-08-28 |
| Completed | Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic De Dermatitis, Atopic | Phase 2 | 2015-08-28 |
| Completed | A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vul Acne Vulgaris | Phase 1 | 2015-04-01 |
| Completed | A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study Plaque Psoriasis | Phase 2 | 2015-04-01 |
| Completed | Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis Plaque Psoriasis | Phase 4 | 2015-01-23 |
| Completed | A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 1 | 2015-01-01 |
| Completed | Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail Onychomycosis | Phase 2 | 2014-12-01 |
| Completed | Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris Acne Vulgaris | Phase 1 | 2014-08-01 |
| Completed | Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis Tinea Pedis | Phase 1 | 2014-06-27 |
| Completed | A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vul Acne Vulgaris | Phase 1 | 2014-06-01 |
| Completed | Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris Acne Vulgaris | Phase 1 | 2014-04-01 |
| Completed | Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tin Tinea Pedis | Phase 1 | 2013-08-01 |
| Completed | A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Comp Secondarily Infected Traumatic Skin Lesions | Phase 1 | 2013-02-01 |
| Completed | Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actin Actinic Keratosis | Phase 1 | 2013-01-01 |
| Completed | Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in Acne Vulgaris | Phase 1 | 2012-11-01 |
| Completed | A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis Actinic Keratosis | Phase 1 | 2012-10-01 |
| Completed | Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the T Acne Vulgaris | Phase 1 | 2012-10-01 |
| Completed | A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Acne Vulgaris | Phase 1 | 2012-09-01 |
| Completed | Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis Tinea Pedis | Phase 1 | 2012-05-01 |
| Completed | Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehic Tinea Pedis | Phase 1 | 2012-01-01 |
| Completed | A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pe Tinea Pedis | Phase 1 | 2011-11-01 |
| Completed | A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea Rosacea | Phase 1 | 2011-08-01 |
| Completed | Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis Psoriasis | Phase 3 | 2010-08-01 |
| Completed | Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis Psoriasis | Phase 3 | 2010-08-01 |
| Terminated | Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Interdigital Tinea Pedis | Phase 1 | 2010-07-01 |
| Completed | Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study Psoriasis | Phase 2 | 2010-02-01 |
| Completed | Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study Psoriasis | Phase 2 | 2009-11-01 |
| Completed | Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lic Pediculosis | Phase 3 | 2009-08-01 |
| Completed | Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lic Pediculosis | Phase 3 | 2009-08-01 |
| Completed | Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice Pediculosis | Phase 1 | 2009-07-01 |
| Completed | Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis Atopic Dermatitis | Phase 1 | 2008-10-01 |
| Completed | Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice Pediculosis | Phase 2 / Phase 3 | 2008-09-01 |
| Completed | Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis Tinea Pedis | Phase 1 | 2008-06-01 |
| Completed | Bioequivalence Study of Two Imiquimod Cream 5% Actinic Keratosis | Phase 1 | 2008-06-01 |
| Terminated | Pilot Efficacy Study of T2000 in Myoclonus Dystonia Myoclonus | Phase 2 | 2007-08-01 |
| Terminated | T2000 in Essential Tremor - Open Label Continuation Essential Tremor | Phase 2 | 2007-08-01 |
| Terminated | A Study of T2000 in Essential Tremor Essential Tremor | Phase 2 | 2006-08-01 |
| Terminated | Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice Lice Infestations | Phase 2 | 2006-02-01 |
| Completed | Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice Lice Infestations | Phase 3 | 2005-12-01 |